CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 66 filers reported holding CUREVAC N V in Q4 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,524,294 | -27.4% | 516,002 | +10.8% | 0.00% | 0.0% |
| Q2 2023 | $4,853,532 | +49.9% | 465,790 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $3,238,547 | +148.9% | 464,641 | +115.3% | 0.00% | – |
| Q4 2022 | $1,301,100 | -57.3% | 215,771 | -44.2% | 0.00% | -100.0% |
| Q3 2022 | $3,049,000 | -67.3% | 386,976 | -43.5% | 0.00% | -50.0% |
| Q2 2022 | $9,326,000 | +69.1% | 685,270 | +143.7% | 0.00% | +100.0% |
| Q1 2022 | $5,515,000 | -53.1% | 281,224 | -18.0% | 0.00% | -50.0% |
| Q4 2021 | $11,760,000 | -9.0% | 342,757 | +44.9% | 0.00% | 0.0% |
| Q3 2021 | $12,921,000 | +141.2% | 236,560 | +224.5% | 0.00% | +100.0% |
| Q2 2021 | $5,356,000 | +247.1% | 72,893 | +331.9% | 0.00% | – |
| Q1 2021 | $1,543,000 | +65.6% | 16,876 | +46.9% | 0.00% | – |
| Q4 2020 | $932,000 | +189.4% | 11,491 | +66.0% | 0.00% | – |
| Q3 2020 | $322,000 | – | 6,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |